by Lonza said it was recruiting from the Swiss labour market as well as from countries such as Germany, France, northern Italy and the United Kingdom. Keystone / Alessandro Della Valle The Swiss pharmaceutical company is recruiting workers to join its new plant in southern Switzerland, where three production lines have been set up to manufacture an active ingredient of Moderna’s Covid-19 vaccine. So far the firm has hired 650 new staff to work at its Visp site in canton Valais, said site director Renzo Cicillini in a media interview published on Saturday. Cicillini added that Lonza was recruiting from the Swiss labour market as well as from countries such as Germany, France, northern Italy and the United Kingdom. The multinational signed a ten-year contract with
Topics:
Swissinfo considers the following as important: 3) Swiss Markets and News, 3.) Swissinfo Business and Economy, Business, Featured, newsletter
This could be interesting, too:
Nachrichten Ticker - www.finanzen.ch writes Krypto-Ausblick 2025: Stehen Bitcoin, Ethereum & Co. vor einem Boom oder Einbruch?
Connor O'Keeffe writes The Establishment’s “Principles” Are Fake
Per Bylund writes Bitcoiners’ Guide to Austrian Economics
Ron Paul writes What Are We Doing in Syria?
Lonza said it was recruiting from the Swiss labour market as well as from countries such as Germany, France, northern Italy and the United Kingdom. Keystone / Alessandro Della Valle
The Swiss pharmaceutical company is recruiting workers to join its new plant in southern Switzerland, where three production lines have been set up to manufacture an active ingredient of Moderna’s Covid-19 vaccine.
So far the firm has hired 650 new staff to work at its Visp site in canton Valais, said site director Renzo Cicillini in a media interview published on Saturday.
Cicillini added that Lonza was recruiting from the Swiss labour market as well as from countries such as Germany, France, northern Italy and the United Kingdom.
The multinational signed a ten-year contract with American firm Moderna in 2020 to supply ingredients for up to one billion doses of its Covid vaccine a year for the global market, excluding the United States. Only in January, Lonza had projected the need for 200 workers in Visp to meet a yearly target of 300 million doses.
Asked whether the Swiss government would support a vaccine production line in Visp, Cicillini said the company’s CEO, Albert Baehny, was in contact with the health minister, Alain Berset, and that the media would be informed of any new development.
Recent media reports claimed that Berset turned down an opportunity last year to secure a vaccine production line exclusively for Switzerland by investing in Lonza, reports that Berset has rejected.
You Might Also Like
Weekly SNB Sight Deposits and Speculative Positions: SNB selling euros and dollars
2021-04-12
Update April 12 2021: SNB selling euros and dollars. Sight Deposits have fallen: The change is -0.5 bn. compared to last week, this means the SNB is selling euros and dollars.
Nestlé attacks food benefits of Brazilian workers during the pandemic
2021-04-03
The Swiss multinational is celebrating 100 years in Brazil but its poorest workers face food voucher cuts amid rising food prices caused by the pandemic. After a century of doing business in Brazil – Nestlé’s fifth largest market with CHF2.79 billion ($2.94 billion) in sales in 2020 – the Swiss food manufacturer faces the discontent of trade unions in the South American country.
Credit Suisse warns of ‘highly significant’ loss linked to hedge fund
2021-03-29
The Swiss bank Credit Suisse says it may face a “highly significant” loss in the first quarter due to an unnamed American hedge fund client defaulting on margin calls. In a statement issued on Monday, the bank said: “While at this time it is premature to quantify the exact size of the loss resulting from this exit, it could be highly significant and material to our first quarter results”.
Swiss spent record amount on food in 2020
2021-02-14
Consumers spent 11.3% more on food and beverages in brick-and-mortar shops last year than they did in 2019, helping the food retail trade to pull in a record turnover of nearly CHF30 billion ($33.7 billion).
Funding for start-ups barely dented by coronavirus
2021-01-26
More than CHF2 billion of venture capital flowed into young Swiss companies for the second year in a row, a sustained rate of funding that defied the economic destruction wreaked by the pandemic last year.
Clariant plans to slash more jobs
2020-11-26
Swiss speciality chemicals firm Clariant has announced further job cuts amid a series of divestments.
Swiss advance plans to take goods transport underground
2020-11-15
Building a 500-km tunnel network to transport goods under Central Switzerland is the ambitious aim of the “Cargo Sous Terrain” project. The vision has moved closer to reality since the Swiss government brought forward enabling legislation last month.
Swiss multinationals: global heavyweights in high-risk sectors
2020-11-12
Home to big players in the raw materials, food and chemicals industries, Switzerland boasts one of the world’s highest concentrations of multinational headquarters.
Tags: Business,Featured,newsletter